A couple of ARK Invest exchange-traded funds run by ETF star Cathie Wood bought over 850,000 shares of Pacific Biosciences of California Inc. (NASDAQ: PACB) altogether on Monday, as the prices of these ETFs were up less than 1% in Monday’s session. These funds are up a fair amount in the past year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 96,000 shares, while ARK Innovation ETF (NYSEARCA: ARKK) bought 756,850 shares. At Monday’s closing price, this would have valued these purchases at roughly $26.6 million altogether. This is only a small fraction of the total holdings. ARKG is up roughly 59% in the past year and ARKK is up 53%.
Check out all of ARK Invest’s buys for Monday:
Fund | Ticker | Company | Shares |
---|---|---|---|
ARKF | ETSY | Etsy | 64,213 |
ARKG | VERV | Verve Therapeutics | 94,600 |
ARKG | SURF | Surface Oncology | 14,000 |
ARKG | SMFR | Sema4 | 551,578 |
ARKG | SGFY | Signify Health | 102,356 |
ARKG | RPTX | Repare Therapeutics | 5,897 |
ARKG | QSI | Quantum-Si | 70,000 |
ARKG | PACB | Pacific Biosciences of California | 96,000 |
ARKG | FATE | Fate Therapeutics | 27,556 |
ARKG | CMIIU | CM Life Sciences II | 5,000 |
ARKG | EDIT | Editas Medicine | 30,356 |
ARKG | MASS | 908 Devices | 10,671 |
ARKK | VCYT | Veracyte | 11,405 |
ARKK | PD | PagerDuty | 167,000 |
ARKK | PACB | Pacific Biosciences of California | 756,850 |
ARKK | CRSP | CRISPR Therapeutics | 55,000 |
ARKK | BEAM | Beam Therapeutics | 81,497 |
ARKQ | MKFG | Markforged | 18,200 |
ARKQ | PATH | UiPath | 283,325 |
ARKQ | SPFR | Jaws Spitfire Acquisition | 74,000 |
ARKQ | U | Unity Software | 166,740 |
ARKQ | LMT | Lockheed Martin | 57,202 |
ARKQ | IRDM | Iridium Communications | 202,159 |
ARKQ | AVAV | AeroVironment | 15,267 |
ARKW | VUZI | Vuzix | 99,712 |
ARKW | PD | PagerDuty | 43,000 |
ARKW | KVSB | Khosla Venture Acquisition II | 90,000 |
ARKW | TWLO | Twilio | 31,572 |
ARKW | ETSY | Etsy | 61,144 |
ARKW | CND | Concord Acquisition | 35,000 |
ARKX | AMZN | Amazon.com | 373 |
ARKX | LMT | Lockheed Martin | 5,784 |
ARKX | SPFR | Jaws Spitfire Acquisition | 16,000 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
Are You Still Paying With a Debit Card?
The average American spends $17,274 on debit cards a year, and it’s a HUGE mistake. First, debit cards don’t have the same fraud protections as credit cards. Once your money is gone, it’s gone. But more importantly you can actually get something back from this spending every time you swipe.
Issuers are handing out wild bonuses right now. With some you can earn up to 5% back on every purchase. That’s like getting a 5% discount on everything you buy!
Our top pick is kind of hard to imagine. Not only does it pay up to 5% back, it also includes a $200 cash back reward in the first six months, a 0% intro APR, and…. $0 annual fee. It’s quite literally free money for any one that uses a card regularly. Click here to learn more!
Flywheel Publishing has partnered with CardRatings to provide coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.